Accelerating the Use of RWD for Oncology Clinical Trial Planning
As medical facilities become more equipped to handle different telemedicine platforms and procedures, more clinical trials are back…
Beyond the Ordinary Beyond the Obvious
As medical facilities become more equipped to handle different telemedicine platforms and procedures, more clinical trials are back…
Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently…
Image Credit: Andy Studna In a session at the 2024 DIA Global Annual meeting in San Diego, CA,…
Image credit: Matthieu | stock.adobe.com Johnson & Johnson has submitted a supplemental Biologics License Application (sBLA) to the…
Sandra Smith, RN, MSN, AOCN, Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG. Site activation of…
ACT: What are currently some of the greatest regulatory challenges industry stakeholders such as CROs and sponsors should…
Image credit: Corona Borealis | stock.adobe.com The clinical research industry has historically operated with a focus on effectively…
ACT: How is FDA promoting innovation in clinical trial design and conduct? Cuff Shimooka: It’s a timely question,…
ACT: What do you think are some of the greatest opportunities for integrating artificial intelligence (AI) into clinical…
Image credit: LASZLO | stock.adobe.com Findings from the Phase II MagnetisMM-3 trial (NCT04649359) showed a significant survival benefit…